Income Statement (TTM)
Shin Nippon Biomedical Laboratories, Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15,175 | 14,910 | 15,110 | 14,978 | 16,068 | 17,636 | 17,748 | 18,753 | 20,135 | 21,173 | 25,090 | 26,848 | 26,626 | 26,703 | 26,450 | 26,195 | 27,074 | 30,701 | 32,413 | 33,342 |
| Change (%) | -1.75 | 1.34 | -0.87 | 7.28 | 9.76 | 0.64 | 5.66 | 7.37 | 5.16 | 18.50 | 7.01 | -0.83 | 0.29 | -0.95 | -0.97 | 3.36 | 13.40 | 5.58 | 2.87 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 7,625 | 7,511 | 7,557 | 7,446 | 7,623 | 8,087 | 8,061 | 8,574 | 9,364 | 9,861 | 12,044 | 12,663 | 12,631 | 12,766 | 13,501 | 13,415 | 12,622 | 15,606 | 15,453 | 18,696 |
| Change (%) | -1.50 | 0.61 | -1.47 | 2.38 | 6.09 | -0.32 | 6.36 | 9.21 | 5.31 | 22.14 | 5.14 | -0.25 | 1.07 | 5.76 | -0.64 | -5.91 | 23.64 | -0.98 | 20.99 | |
| % of Revenue | 50.25 | 50.38 | 50.01 | 49.71 | 47.44 | 45.86 | 45.42 | 45.72 | 46.51 | 46.57 | 48.00 | 47.17 | 47.44 | 47.81 | 51.04 | 51.21 | 46.62 | 50.83 | 47.68 | 56.07 |
| Gross Operating Profit | 7,550 | 7,399 | 7,553 | 7,532 | 8,445 | 9,549 | 9,687 | 10,179 | 10,771 | 11,312 | 13,046 | 14,185 | 13,995 | 13,937 | 12,949 | 12,780 | 14,452 | 15,095 | 16,960 | 14,646 |
| Change (%) | -2.00 | 2.08 | -0.28 | 12.12 | 13.07 | 1.45 | 5.08 | 5.82 | 5.02 | 15.33 | 8.73 | -1.34 | -0.41 | -7.09 | -1.31 | 13.08 | 4.45 | 12.35 | -13.65 | |
| % of Revenue | 49.75 | 49.62 | 49.99 | 50.29 | 52.56 | 54.14 | 54.58 | 54.28 | 53.49 | 53.43 | 52.00 | 52.83 | 52.56 | 52.19 | 48.96 | 48.79 | 53.38 | 49.17 | 52.32 | 43.93 |
| SG&A | 4,692 | 4,574 | 4,482 | 4,417 | 4,566 | 4,803 | 4,908 | 5,178 | 5,648 | 6,050 | 6,894 | 7,520 | 7,806 | 9,033 | 8,525 | 9,729 | 10,558 | 11,313 | 11,369 | 9,248 |
| Change (%) | -2.51 | -2.01 | -1.45 | 3.37 | 5.19 | 2.19 | 5.50 | 9.08 | 7.12 | 13.95 | 9.08 | 3.80 | 15.72 | -5.62 | 14.11 | 8.53 | 7.15 | 0.49 | -18.65 | |
| % of Revenue | 30.92 | 30.68 | 29.66 | 29.49 | 28.42 | 27.23 | 27.65 | 27.61 | 28.05 | 28.57 | 27.48 | 28.01 | 29.32 | 33.83 | 32.23 | 37.14 | 39.00 | 36.85 | 35.08 | 27.74 |
| R&D | 400 | 400 | 392 | 392 | 392 | 392 | 425 | 425 | 425 | 425 | 683 | 683 | 683 | 683 | 1,741 | 2,217 | 2,218 | |||
| Change (%) | 0.00 | -2.00 | 0.00 | 0.00 | 0.00 | 8.42 | 0.00 | 0.00 | 0.00 | 60.71 | 0.00 | 0.00 | 0.00 | 0.03 | ||||||
| % of Revenue | 2.64 | 2.68 | 2.59 | 2.62 | 2.44 | 2.22 | 2.39 | 2.27 | 2.11 | 2.01 | 2.72 | 2.54 | 2.57 | 2.56 | 6.43 | 6.84 | 6.65 | |||
| OpEx | 12,864 | 12,632 | 12,581 | 12,405 | 12,731 | 13,432 | 13,552 | 14,335 | 15,595 | 16,494 | 19,845 | 21,090 | 21,344 | 22,706 | 22,288 | 23,405 | 25,182 | 27,181 | 29,428 | 30,552 |
| Change (%) | -1.80 | -0.40 | -1.40 | 2.63 | 5.51 | 0.89 | 5.78 | 8.79 | 5.76 | 20.32 | 6.27 | 1.20 | 6.38 | -1.84 | 5.01 | 7.59 | 7.94 | 8.27 | 3.82 | |
| % of Revenue | 84.77 | 84.72 | 83.26 | 82.82 | 79.23 | 76.16 | 76.36 | 76.44 | 77.45 | 77.90 | 79.10 | 78.55 | 80.16 | 85.03 | 84.26 | 89.35 | 93.01 | 88.53 | 90.79 | 91.63 |
| Operating Income | 2,311 | 2,278 | 2,529 | 2,573 | 3,337 | 4,204 | 4,196 | 4,418 | 4,540 | 4,679 | 5,245 | 5,758 | 5,282 | 3,997 | 4,162 | 2,790 | 1,892 | 3,521 | 2,985 | 2,789 |
| Change (%) | -1.43 | 11.02 | 1.74 | 29.69 | 25.98 | -0.19 | 5.29 | 2.76 | 3.06 | 12.10 | 9.78 | -8.27 | -24.33 | 4.14 | -32.97 | -32.19 | 86.08 | -15.21 | -6.55 | |
| % of Revenue | 15.23 | 15.28 | 16.74 | 17.18 | 20.77 | 23.84 | 23.64 | 23.56 | 22.55 | 22.10 | 20.90 | 21.45 | 19.84 | 14.97 | 15.74 | 10.65 | 6.99 | 11.47 | 9.21 | 8.37 |
| Interest Expense | -213 | -200 | -184 | -168 | -151 | -138 | -126 | -119 | -119 | -118 | -125 | -133 | -126 | -131 | -139 | -142 | -169 | -190 | -202 | -220 |
| Change (%) | -6.10 | -8.00 | -8.70 | -10.12 | -8.61 | -8.70 | -5.56 | -0.00 | -0.84 | 5.93 | 6.40 | -5.26 | 3.97 | 5.94 | 2.60 | 18.69 | 12.50 | 6.24 | 8.91 | |
| % of Revenue | -1.40 | -1.34 | -1.22 | -1.12 | -0.94 | -0.78 | -0.71 | -0.63 | -0.59 | -0.56 | -0.50 | -0.50 | -0.47 | -0.49 | -0.52 | -0.54 | -0.62 | -0.62 | -0.62 | -0.66 |
| Net Income | 2,812 | 2,421 | 3,661 | 4,844 | 6,025 | 7,432 | 7,127 | 7,245 | 8,043 | 6,231 | 6,060 | 5,489 | 4,607 | 5,503 | 5,531 | 4,280 | 3,896 | 4,942 | 4,924 | 5,063 |
| Change (%) | -13.90 | 51.22 | 32.31 | 24.38 | 23.35 | -4.10 | 1.66 | 11.01 | -22.53 | -2.74 | -9.42 | -16.07 | 19.45 | 0.51 | -22.62 | -8.97 | 26.85 | -0.37 | 2.82 | |
| % of Revenue | 18.53 | 16.24 | 24.23 | 32.34 | 37.50 | 42.14 | 40.16 | 38.63 | 39.95 | 29.43 | 24.15 | 20.44 | 17.30 | 20.61 | 20.91 | 16.34 | 14.39 | 16.10 | 15.19 | 15.19 |
Source: Capital IQ
